FluidAI lands FDA clearance to sell post-surgery monitor in the US | BetaKit
The Kitchener-Waterloo healthtech startup is eying Series B funding to fuel its US commercialization.| BetaKit
The Kitchener-Waterloo healthtech startup is eying Series B funding to fuel its US commercialization.| BetaKit
FluidAI Medical gains FDA clearance to sell Origin, their post-surgery monitor to detect any complications during recovery, to the US market.| Innovation Factory
